Johnson & Johnson said a judge threw out a woman’s lawsuit arguing a vaginal-mesh implant was defectively designed, ending the first trial of claims the sling caused patients’ injuries.
Johnson & Johnson is set to face its first trial over its vaginal mesh implant in a case brought by a South Dakota woman who blames the product for constant pain and 18 subsequent operations.
Johnson & Johnson sold a vaginal mesh implant for three years before U.S. regulators approved the device, now the subject of more than 550 lawsuits by women who claim it injured them.
Johnson & Johnson improperly destroyed files about some vaginal-mesh implants and may have to let juries weighing lawsuits over the devices hear evidence about the destruction, a court official said.
Johnson & Johnson, the world’s second-biggest health-care products maker, is battling lawsuits over a vaginal implant based on a similar device pulled from the market more than a decade ago for safety reasons.
The Australian bond market may grow 44 percent to about A$740 billion ($785 billion) by June 2015, led by increases in debt sales from regional governments and corporate issuers, UBS AG said.
The path from football to Wall Street is well-worn. Now the championship-winning 1986 team at Penn State University is retracing its steps.
The Australian dollar’s world- beating rally in the past three months and bets it will extend those gains are fueling speculation policy makers will try to talk down the currency.
"The reason the spread is tightening is because bond investors are very focused on the slowdown in China and the decline in commodity prices."
- Matthew Johnson on Dec 02, 2014